Find your path to Elona
99 people in our graph share verified history with Elona — schools, employers, funds. One of them is your warm intro.
About
Elona Baum is a Managing Director at DEFTA Partners, where she leads the healthcare technologies fund focused on early-stage investments in therapeutic and digital health innovations. With over 20 years in drug development, she previously held leadership positions at Genentech and the California Institute for Regenerative Medicine, where she oversaw $1 billion in regenerative medicine investments and managed intellectual property and regulatory matters. She currently serves as a board director for multiple healthcare and biotechnology companies including Endogena, Abilitech, Aegle, BioEclipse, and Orig3n.
Board director at Aegle Therapeutics
Intro paths
In turn, Elona can intro founders to Aegle Therapeutics's investors below.
Aegle Therapeutics's investors · 3
Co-founders at Aegle Therapeutics
Experience
- Entrepeneurs Futures NetworkMentorcurrent2014 — present
- DEFTA PartnersManaging Director2015 — 2022San Francisco
- Endogena Therapeutics, BioEclipse, Abilitech, Orig3n, Cancer Prevention Inst. of California (CPIC)Board Member2014 — 2022
- Coherus BioSciencesVP, Associate General Counsel2014 — 2015
- California Inst. for Regenerative MedicineGeneral Counsel and VP Business Development2009 — 2014
- GenentechAssociate General Counsel/Director Regulatory Policy & Strategy1996 — 2009South San Francisco, CA
- Carroll, Burdick and McDounoughAttorney1993 — 1996
- Steefel, Levitt and WeissAttorney1989 — 1993
Skills & more
+12 more
Intellectual PropertyMergers & AcquisitionsDrug DevelopmentCommercializationRegulatory AffairsDue DiligenceLicensingCancerImmunologyBiochemistryMolecular BiologyClinical Development- Regulatory Affairs Professional — Regulatory Affairs Professionals Society (RAPS)
From Elona's professional profile.
Network3
Investors connected to Elona in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Elona Baum?
- Elona Baum is a Managing Director at DEFTA Partners, where she leads the healthcare technologies fund focused on early-stage investments in therapeutic and digital health innovations. With over 20 years in drug development, she previously held leadership positions at Genentech and the California Institute for Regenerative Medicine, where she oversaw $1 billion in regenerative medicine investments and managed intellectual property and regulatory matters. She currently serves as a board director for multiple healthcare and biotechnology companies including Endogena, Abilitech, Aegle, BioEclipse, and Orig3n.
- Where does Elona Baum work?
- Elona Baum is Board director at Aegle Therapeutics.
- What check size does Elona Baum write?
- Elona Baum typically writes checks of $500K – $3M.
- Where did Elona Baum go to school?
- Elona Baum studied at University of San Francisco School of Law; UCLA (Bachelor of Arts - BA, Economics).
Same school
Also attended University of San Francisco School of Law11
+ 5 more
Also attended UCLA835
+ 829 more
Shared employers
Also worked at DEFTA Partners6
Also worked at Coherus BioSciences4
Also worked at Genentech174
+ 168 more